WASHINGTON (MedPage Today) -- Percutaneous patent foramen ovale (PFO) closure did not significantly reduce the number of monthly migraine days compared with medical treatment, researchers reported here.
(MedPage Today) -- Calling the Ebola epidemic in West Africa a "potential threat to global security," President Barack Obama said the U.S. will send 3,000 military personnel to help combat the outbreak.
SAN FRANCISCO (MedPage Today) -- Combined-modality treatment for early Hodgkin's lymphoma led to significantly better overall survival as compared with patients who received chemotherapy without radiotherapy.
WASHINGTON (MedPage Today) -- The BRIGHT trial favored bivalirudin (Angiomax) over heparin in PCI, but was the heparin dose responsible? In this exclusive video, Rod H. Stables, MA, DM, discusses some caveats.
(MedPage Today) -- Two previously unrecognized autoinflammatory syndromes characterized by periodic fevers and other systemic symptoms have been linked with mutations in the NLRC4 gene.
(MedPage Today) -- When withdrawing therapy in juvenile idiopathic arthritis patients with inactive disease, flares were less likely when methotrexate was stopped first before TNF inhibitors, a retrospective study found.
WASHINGTON (MedPage Today) -- In a small study using ambulatory systolic pressure readings as an endpoint, renal sympathetic denervation did not achieve a benefit in patients with mild but treatment-resistant hypertension.
(MedPage Today) -- Patients experiencing opioid-induced constipation will have another treatment option, thanks to the FDA's approval of naloxegol (Movantik) on Tuesday.
(MedPage Today) -- COLLEGE PARK, Md. -- Testosterone therapy and its potential cardiovascular risks will be front and center during a 2-day FDA joint advisory committee meeting that starts here on Wednesday.
BOSTON (MedPage Today) -- Women using combined oral contraceptives containing norethindrone or levonorgestrel were substantially more likely to develop multiple sclerosis than those not on "The Pill."